InvestSMART

Zelira Therapeutics Limited (ASX: ZLD) - Announcements

- Current share price for ZLD : $0.500

ASX company news and announcements for Zelira Therapeutics Limited (ZLD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Zelira Therapeutics Limited (ZLD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Zelira Therapeutics Limited (ZLD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Zelira Therapeutics Limited (ZLD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$7 Initial Director's Interest Notice x 3 4 Dec 2019 2:30PM $0.065 $0.500 risen by 669.23%
$7 Zelira Therapeutics expands HOPE distribution in the U.S.A 4 Dec 2019 8:25AM $0.065 $0.500 risen by 669.23%
$7 Final Director's Interest Notice 2 Dec 2019 12:19PM $0.066 $0.500 risen by 657.58%
$7 Ilera Therapeutics Merger Completed and Board Changes 2 Dec 2019 8:58AM $0.067 $0.500 risen by 646.27%
$7 New Constitution 28 Nov 2019 5:24PM $0.067 $0.500 risen by 646.27%
$7 Results of Meeting 28 Nov 2019 1:52PM $0.067 $0.500 risen by 646.27%
$7 2019 AGM Chairman's Address 28 Nov 2019 12:26PM $0.067 $0.500 risen by 646.27%
$7 Annual General Meeting Presentation 2019 28 Nov 2019 11:45AM $0.067 $0.500 risen by 646.27%
$7 Investor Presentation - Non-deal Roadshow 25 Nov 2019 8:21AM $0.069 $0.500 risen by 624.64%
$7 Agreement with Health House to Distribute Zelda Products 21 Nov 2019 8:21AM $0.066 $0.500 risen by 657.58%
$7 Update on Global Launch Strategy for HOPE Range of Products 20 Nov 2019 8:34AM $0.067 $0.500 risen by 646.27%
$7 Formulations to be supplied as part of CARE NSW trial 14 Nov 2019 8:21AM $0.067 $0.500 risen by 646.27%
$7 R&D Tax Incentive Refund 11 Nov 2019 8:14AM $0.067 $0.500 risen by 646.27%
$7 Zeldas Phase II Insomnia Clinical Trial Fully Enrolled 7 Nov 2019 8:21AM $0.068 $0.500 risen by 635.29%
$7 Appendix 4C - quarterly 31 Oct 2019 2:08PM $0.066 $0.500 risen by 657.58%
$7 September 2019 Quarterly Report 31 Oct 2019 1:58PM $0.066 $0.500 risen by 657.58%
$7 Notice of Annual General Meeting 25 Oct 2019 7:49PM $0.070 $0.500 risen by 614.29%
$7 Becoming a substantial holder 16 Oct 2019 3:27PM $0.073 $0.500 risen by 584.93%
$7 Zelira Transaction Investor Teleconference and Q&A 15 Oct 2019 1:17PM $0.067 $0.500 risen by 646.27%
$7 Appendix 3B and Cleansing Notice 10 Oct 2019 4:54PM $0.076 $0.500 risen by 557.89%
$7 Investor Presentation - Zelira - Non Deal Roadshow 9 Oct 2019 11:58AM $0.080 $0.500 risen by 525%
$7 Zelda to merge with US-based Ilera Therapeutics 9 Oct 2019 9:58AM $0.078 $0.500 risen by 541.03%
$7 Trading Halt 8 Oct 2019 10:13AM $0.078 $0.500 risen by 541.03%
$7 Pause in Trading 8 Oct 2019 9:56AM $0.078 $0.500 risen by 541.03%
$7 Appendix 3B 27 Sep 2019 6:57PM $0.075 $0.500 risen by 566.67%

351 - 375 of 546 results

Page 15 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.